Literature DB >> 33371885

Long non-coding RNA LBX2-AS1 enhances glioma proliferation through downregulating microRNA-491-5p.

Qunbang Chen1, Jian Gao1, Yingjia Zhao2, Ruizhe Hou3.   

Abstract

BACKGROUND: Dysregulation of lncRNAs is frequent in glioma and has emerged as an important mechanism involved in tumorigenesis. Previous analysis of Chinese Glioma Genome Atlas (CGGA) database indicated that LBX2-AS1 expression is one of differentially expression lncRNA between lower grade glioma (LGG) (grade II and III) and glioblastoma multiforme (GBM). However, the function and mechanism of LBX2-AS1 in glioma has not been evaluated yet.
METHODS: Here, we analyzed the expression of LBX2-AS1 in GTEx data (normal brain), TCGA-LGG and TCGA-GBM. RT-PCR was performed to detect LBX2-AS1 in surgery obtained normal brain and glioma. CCK-8 kit and Annexin V-FITC-PI Apoptosis Detection Kit were used to study the function of LBX2-AS1 on glioma proliferation and apoptosis. Bioinformatic analysis, RNA immunoprecipitation, RT-PCR, western blotting and dual luciferase reporter assay were carried out to investigate the target miRNA of LBX2-AS1. The discovered mechanism was validated by the rescue assay.
RESULTS: Following study of GTEx and TCGA data, LBX2-AS1 was significantly elevated in glioma compared with normal brain and in GBM compared with LGG. Higher expression of LBX2-AS1 was associated with poor prognosis of patients with glioma. Expression of LBX2-AS1 was positively correlated with pathology classification of glioma. Knockdown of LBX2-AS1 inhibited cell proliferation and induced cell apoptosis in glioma. LBX2-AS1 have complimentary binding site for tumor suppressor miR-491-5p and we showed that LBX2-AS1 sponged miR-491-5p to upregulate TRIM28 expression in glioma cells. TRIM28 overexpression attenuated the effect of LBX2-AS1 knockdown on glioma cells.
CONCLUSIONS: In conclusion, LBX2-AS1 was an increased lncRNA in glioma. Mechanistically, LBX2-AS1 promoted glioma cell proliferation and resistance to cell apoptosis via sponging miR-491-5p.

Keywords:  Cell apoptosis; Cell proliferation; Glioma; LBX2-AS1; TRIM28; miR-491-5p

Year:  2020        PMID: 33371885     DOI: 10.1186/s12935-020-01433-2

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  5 in total

1.  MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.

Authors:  Yanjun Xu; Rui Hou; Qijie Lu; Yang Zhang; Lei Chen; Yuanyi Zheng; Bing Hu
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 2.  TRIM proteins and diseases.

Authors:  Masashi Watanabe; Shigetsugu Hatakeyama
Journal:  J Biochem       Date:  2017-02-01       Impact factor: 3.387

3.  Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.

Authors:  L-X Tang; S-F Su; Q Wan; P He; Y Xhang; X-M Cheng
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-09       Impact factor: 3.507

4.  Upregulation of LGMNP1 confers radiotherapy resistance in glioblastoma.

Authors:  Hao Xu; Binghong Chen; Jin Xing; Zilong Wei; Chaobo Liu; Yongming Qiu; Yingying Lin; Li Ren
Journal:  Oncol Rep       Date:  2019-04-18       Impact factor: 3.906

5.  TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.

Authors:  Fan Li; Zhijie Wang; Gaochuan Lu
Journal:  Oncol Rep       Date:  2018-01-26       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.